NCT00324922View on ClinicalTrials.gov

Vancomycin Or Trimethoprim/Sulfamethoxazole for Methicillin-resistant Staphylococcus Aureus Osteomyelitis

PHASE3CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

May 1, 2006

Primary Completion Date

May 1, 2007

Study Completion Date

May 1, 2007

Conditions
OsteomyelitisMethicillin-resistant Staphylococcus Aureus
Interventions
DRUG

trimethoprim-sulfamethoxazole

trimethoprim/sulfamethoxazole 320/1600 mg po bid

DRUG

vancomycin

1g iv bid

Trial Locations (1)

98104

University of Washington, Seattle

All Listed Sponsors
lead

University of Washington

OTHER

NCT00324922 - Vancomycin Or Trimethoprim/Sulfamethoxazole for Methicillin-resistant Staphylococcus Aureus Osteomyelitis | Biotech Hunter | Biotech Hunter